A Pilot Study: Changing Multiple Behaviors in Post-Angioplasty Patients
We are interested in achieving an empirical test of the two intervention approaches under study. Specifically, we seek to determine the potential differential impact of positive affect induction and self affirmation following the qualitative study phase.
Behavioral: Positive affect induction and /or self affirmation induction
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
|Official Title:||A Pilot Study: Changing Multiple Behaviors in Post-Angioplasty Patients|
- Within patient change on the Positive and Negative Affect Scale
|Study Start Date:||February 2004|
|Estimated Study Completion Date:||June 2004|
We seek to determine the potential differential impact of positive affect induction and self affirmation following the qualitative study phase.
- Positive affect induction: We will tests two types of positive affect induction. 1) sending patients a small gift, and 2) reminding patients of positive thoughts about themselves. Gift: Prior to a telephone call, patients in the positive affect condition will receive a small gift. The selection of gifts will be guided, in part, by data obtained from the qualitative study phase. Positive thoughts about themselves: Patients will be asked to describe a time when someone was helpful to them, and they felt good about it , and were nice to them in return.
- Self affirmation: consists of a series of items reminding people of their core values.
- Control: Control patients will have neither self affirmation nor gifts. After enrollment, patients will be randomized into four groups: control, the self affirmation, the positive affect gift group and the positive affect positive thought group. Thus, for the positive affect, we will test two different types of positive affect induction.
Follow-up: At two weeks after enrollment all patients will be called to ascertain impact of the pilot intervention.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00248950
|United States, New York|
|The New York Presbyterian Hospital-Weill Medical Center|
|New York, New York, United States, 10021|
|Principal Investigator:||Mary E Charlson, MD||Weill Medical College of Cornell University|